An observational study in Myopia and High Myopia, sponsored by Suphi Taneri. Recruiting at 1 site in Germany. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-11-29.
Sponsored by Suphi Taneri · Observational
Small Incision Lenticule Extraction (SMILE) was introduced in 2011 using the VISUMAX femtosecond laser (Carl Zeiss Meditec, Jena, Germany). It is designed for correction of myopia and myopic astigmatism.
It involves the creation of a corneal tissue disk called lenticule and its extraction through a minimally invasive incision, utilizing only a femtosecond laser. This enables rapid visual recovery with very little discomfort to the patient.
This observational case series monitors visual and refractive outcomes of myopic correction for more than -7.75 D.
It is to
984 studies on the registry are indexed under Myopia; 210 are open to participants now.
This study's planned enrollment of 5,000 is above the median of 150 across 173 observational studies indexed under Myopia.
Browse Myopia studies →Suphi Taneri is the lead sponsor of 2 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Adult patients with myopia more than -7.75 D seeking refractive surgery
Exclusion Criteria:
SMILE - Correction of eyes with myopia of more than -7.75 D
Other: Small Incision Lenticule Extraction (SMILE) with Visumax (Carl Zeiss Meditec, Jena)
Creation of a corneal tissue disk called lenticule and extraction through a minimally invasive incision, utilizing only a femtosecond laser
Also known as: RelaxSmile
Subjective Distance Refraction
Subjective Refraction
Time frame: 1 year
Distance Visual Acuity
Visual Acuity sine and cum correctione
Time frame: 1 year
Tectonic stability as assessed by Pentacam
Corneal tectonic stability post surgery as assesed by Scheimpflug-Tomography
Time frame: 1 year
Epithelial thickness map in Optical coherence tomography
Change of Thickness of epithelium pre and post surgery
Time frame: 1 year
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Suphi Taneri